| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |